NZ501987A - Single, high dosage intravenous administration of estramustine phosphate - Google Patents

Single, high dosage intravenous administration of estramustine phosphate

Info

Publication number
NZ501987A
NZ501987A NZ501987A NZ50198799A NZ501987A NZ 501987 A NZ501987 A NZ 501987A NZ 501987 A NZ501987 A NZ 501987A NZ 50198799 A NZ50198799 A NZ 50198799A NZ 501987 A NZ501987 A NZ 501987A
Authority
NZ
New Zealand
Prior art keywords
intravenous administration
estramustine phosphate
high dosage
dosage intravenous
estramustine
Prior art date
Application number
NZ501987A
Inventor
Per-Olv Gunnarsson
Michael S Kopreski
Beryl Asp
Bo Fredholm
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NZ501987A publication Critical patent/NZ501987A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An intravenous formulation of estramustine phosphate for use in combination with other anti-cancer therapies.
NZ501987A 1998-03-27 1999-03-26 Single, high dosage intravenous administration of estramustine phosphate NZ501987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7954298P 1998-03-27 1998-03-27
PCT/US1999/004275 WO1999049869A1 (en) 1998-03-27 1999-03-26 Methods to potentiate intravenous estramustine phosphate

Publications (1)

Publication Number Publication Date
NZ501987A true NZ501987A (en) 2002-10-25

Family

ID=22151209

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ501987A NZ501987A (en) 1998-03-27 1999-03-26 Single, high dosage intravenous administration of estramustine phosphate

Country Status (16)

Country Link
EP (1) EP1003521A4 (en)
JP (1) JP2001508810A (en)
KR (1) KR20010021656A (en)
CN (2) CN1636598A (en)
AU (1) AU750010B2 (en)
BR (1) BR9906425A (en)
CA (1) CA2295049A1 (en)
EA (1) EA004647B1 (en)
HU (1) HUP0200547A3 (en)
ID (1) ID24504A (en)
IL (1) IL133612A0 (en)
NO (1) NO20002343L (en)
NZ (1) NZ501987A (en)
PL (1) PL342969A1 (en)
WO (1) WO1999049869A1 (en)
ZA (1) ZA997821B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003201D0 (en) * 2000-02-11 2000-04-05 Pharmacia & Upjohn Spa Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) * 2000-07-25 2002-08-20 Pharmacia & Upjohn Company Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (en) * 2011-05-04 2013-01-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Method of treating colonic liver metastases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617292A (en) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst Method for producing estracyt compound bonded with carcinostatic agent
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
MX9203808A (en) * 1987-03-05 1992-07-01 Liposome Co Inc HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS.
ES2148223T3 (en) * 1992-03-23 2000-10-16 Univ Georgetown TAXOL ENCAPSULATED IN LIPOSOMES AND METHOD FOR USE.
FR2697752B1 (en) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Antitumor compositions containing taxane derivatives.

Also Published As

Publication number Publication date
WO1999049869A1 (en) 1999-10-07
CN1636598A (en) 2005-07-13
HUP0200547A2 (en) 2002-07-29
JP2001508810A (en) 2001-07-03
EA004647B1 (en) 2004-06-24
ID24504A (en) 2000-07-20
KR20010021656A (en) 2001-03-15
ZA997821B (en) 2000-08-01
EP1003521A1 (en) 2000-05-31
NO20002343D0 (en) 2000-05-04
PL342969A1 (en) 2001-07-16
EP1003521A4 (en) 2003-07-23
CA2295049A1 (en) 1999-10-07
HUP0200547A3 (en) 2003-07-28
EA199901081A1 (en) 2000-12-25
CN1273530A (en) 2000-11-15
AU750010B2 (en) 2002-07-11
NO20002343L (en) 2000-05-04
BR9906425A (en) 2000-07-11
IL133612A0 (en) 2001-04-30
AU3353399A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
HK1036969A1 (en) Compounds and compositions for delivering active agents
HK1036970A1 (en) Compounds and compositions for delivering active agents.
EP0993831A3 (en) Compounds and compositions for delivering active agents
AU2274201A (en) Compounds and compositions for delivering active agents
MXPA01008611A (en) Compounds and compositions for delivering active agents.
AU7315301A (en) Compounds and compositions for delivering active agents
TR200002299T2 (en) Epothilon compositions.
AU4451101A (en) Method and compositions for preventing hormone induced adverse effects
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007837A (en) Compositions for delivering bisphosphonates.
GEP20063773B (en) Steroid Sulphatase Inhibitors
CA2244209A1 (en) Improved concentrated injection and infusion solutions for intravenous administration
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
WO2002028832A3 (en) Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
MXPA03007857A (en) Compounds and compositions for delivering active agents.
AU2084801A (en) Antiviral medication
AU2003253506A1 (en) Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
WO1999002143A3 (en) Medicament comprising adenosine
IL140716A0 (en) Use of inhibitors of protein kinase c epsilon to treat pain
IL148513A0 (en) Formulations for parenteral use of estramustine phosphate and amino acids
NZ501987A (en) Single, high dosage intravenous administration of estramustine phosphate
HK1057489A1 (en) Medicament for treating chronic hepatitis b
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
AU2001289762A1 (en) Pharmaceutical extemporary compositions
GR3018931T3 (en) Slow-release ibuprofen-containing medicament and its use.

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed